Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
4 results loaded, newest first. End of these results.
For best results when printing this announcement, please click on link below: Qare™ Is Here: Lōkahi Therapeutics™ Launches a Proprietary New Way to Compare Your Care, Beginning with GLP-1 Medications Now free on the App Store and Google Play, Qare matches users into cohorts by medication and demographic profile, genera
Glucotrack subsidiary Lōkahi Therapeutics announced the public launch of Qare, a platform for comparing self-reported treatment experiences across medications in the same therapeutic class. It is launching initially with GLP-1 medications.
Lōkahi Therapeutics, a subsidiary of Glucotrack, Inc., has launched Qare™, a new comparative health platform designed to evaluate treatment outcomes by comparing patient experiences across different medications within the same therapeutic class, specifically for GLP-1 medications. The platform becomes publicly availabl
Lōkahi Therapeutics, a subsidiary of Glucotrack Inc. (NASDAQ: GCTK), announced Qare™, a comparative health platform designed to evaluate treatment outcomes by comparing experiences across patients using different medications within the same therapeutic class. The platform is expected to become publicly available on Oct